# Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer

> **NCT05230771** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fujian Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Metastatic Gastric Cancer
- Surgery
- Chemotherapy

## Interventions

- **COMBINATION_PRODUCT:** Palliative surgery after translational therapy
- **DRUG:** Chemotheraoy along

## Key facts

- **NCT ID:** NCT05230771
- **Lead sponsor:** Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05230771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05230771, "Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05230771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*